Azelastine

CAS No. 58581-89-8

Azelastine( —— )

Catalog No. M15153 CAS No. 58581-89-8

Azelastine is a potent, second-generation, selective, histamine antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 47 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Azelastine
  • Note
    Research use only, not for human use.
  • Brief Description
    Azelastine is a potent, second-generation, selective, histamine antagonist.
  • Description
    Azelastine is a potent, second-generation, selective, histamine antagonist.
  • In Vitro
    Azelastine can significantly inhibit HNEpC proliferation, and therefore, be helpful in against airway remodeling.Cell Proliferation Assay Cell Line:Human nasal epithelial cells (HNEpC)Concentration:100 μM, 400 μM Incubation Time:21 days Result:Inhibited HNEpC growth.Western Blot Analysis Cell Line:Human nasal epithelial cells (HNEpC) Concentration:100 μM Incubation Time:7 days Result:Significantly up-regulated the H1R, M1R and M3R levels.
  • In Vivo
    Azelastine (4 mg/kg; p.o.; daily; for 8 weeks) significantly reduces blood glucose, HbA1c and serum alkaline phosphatase (ALP), osteocalcin and downregulates apolipoprotein B in diabetic hyperlipidemic rats model.Azelastine (4 mg/kg; p.o.; daily; for 8 weeks) improves the lipid profile (LDL-c decrease and HDL-c increase) in diabetic hyperlipidemic rats model.Azelastine (4 mg/kg; p.o.; daily; for 8 weeks) attenuates calcium deposition and aortic calcification in diabetic hyperlipidemic rats model. Animal Model:Male albino Wistar rats (150-170 g), diabetic hyperlipidemic rats modelDosage:4 mg/kg Administration:Oral administration, daily, for 8 weeks Result:Ameliorated aortic calcification and increased apolipoprotein A expression along with a decline in apolipoprotein B.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    H1 receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    58581-89-8
  • Formula Weight
    381.9
  • Molecular Formula
    C22H24ClN3O
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    CN1CCCC(CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=CC=CC=C2C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Casale TB. J Allergy Clin Immunol. 1989 Apr;83(4):771-6.
molnova catalog
related products
  • Clobenpropit dihydro...

    Clobenpropit dihydrobromide is a potent ?antagonist and inverse agonist of histamine H3R (histamine H3LR,pEC50 of 8.07)Clobenpropit inhibited cell migration and increased apoptosis of pancreatic cancer cells in combination with gemcitabine.?

  • Pitolisant

    A potent and selective antagonist of H3 receptor with Ki/EC50 of 0.16/1.5 nM; no effect on H1, H2, H4 receptors (IC50>10 uM).

  • KSK68

    KSK68 is a potent dual sigma-1 and histamine H3 receptor antagonist with potential analgesic activity and high affinity for H3 receptors, sigma-1, sigma-2 receptors.KSK68 can be used in the study of pain related diseases.